WHO ending hydroxycholorquine trial for COVID

WHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir "produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2NYAhr4
via IFTTT

0 comments:

Post a Comment